The FNAIT Journey: Sharing
Explore insights and strategies for managing FNAIT long-term.
-
-
Demand on the rise for matched platelet transfusions in Canada
-
Study pinpoints anti-HPA-1a antibodies that may raise FNAIT risk
-
Targeted immunotherapy for FNAIT shows early promise
-
Researchers pinpoint molecule that may worsen brain bleed injuries
-
Case report: Failed platelet transfusion due to HLA, HPA antibodies
-
Pathogen reduction technologies could improve FNAIT treatment
